| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alcoholism | |||||
| Depression | |||||
| 2 | More general conditions related to this trial | ||||
| Alcohol-Related Disorders | |||||
| Behavioral Symptoms | |||||
| Disorders of Environmental Origin | |||||
| Mental Disorders | |||||
| Substance-Related Disorders | |||||
| 3 | Interventions listed in this trial | ||||
| sertraline (Zoloft) | |||||
| cognitive behavior therapy | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Sertraline | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antidepressive Agents | |||||
| Central Nervous System Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |||||
|
